109 related articles for article (PubMed ID: 15878201)
1. Fusion protein of CDR mimetic peptide with Fc inhibit TNF-alpha induced cytotoxicity.
Qin W; Feng J; Li Y; Lin Z; Shen B
Mol Immunol; 2006 Feb; 43(6):660-6. PubMed ID: 15878201
[TBL] [Abstract][Full Text] [Related]
2. A novel TNFalpha antagonizing peptide-Fc fusion protein designed based on CDRs of TNFalpha neutralizing monoclonal antibody.
Qin W; Feng J; Zhang W; Li Y; Shen B
Biochem Biophys Res Commun; 2004 Sep; 322(3):1024-8. PubMed ID: 15336567
[TBL] [Abstract][Full Text] [Related]
3. A novel human scFv fragment against TNF-alpha from de novo design method.
Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
[TBL] [Abstract][Full Text] [Related]
4. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
Qin W; Feng J; Li Y; Lin Z; Shen B
Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
[TBL] [Abstract][Full Text] [Related]
5. [Expression of TPO mimetic peptide chimeric proteins with human IgG1 Fc fragments and their biological characters].
Li YX; Li C; Tao KH; Jia XH; Cheng DS; Huang PT
Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):424-30. PubMed ID: 12385237
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor necrosis factor-alpha reduces alveolar septal cell apoptosis in passive smoking rats.
Zhang C; Cai S; Chen P; Chen JB; Wu J; Wu SJ; Zhou R
Chin Med J (Engl); 2008 Apr; 121(7):597-601. PubMed ID: 18466678
[TBL] [Abstract][Full Text] [Related]
7. [Cloning, expression and bio-activity assay of chimeric fusion protein sTNFRII-IgG Fc].
Xu CX; Yao LH; Zu D; Chen AJ; Huang GJ; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(2):178-81. PubMed ID: 12148279
[TBL] [Abstract][Full Text] [Related]
8. Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay.
Löfdahl PA; Nord O; Janzon L; Nygren PA
N Biotechnol; 2009 Nov; 26(5):251-9. PubMed ID: 19576305
[TBL] [Abstract][Full Text] [Related]
9. [Cloning and expression of human TNFR (P55)-IgG Fc fusion protein in eukaryotic cells].
An N; Xu C; Zhang Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):116-7. PubMed ID: 11436637
[TBL] [Abstract][Full Text] [Related]
10. Rational design of potent mimic peptide derived from monoclonal antibody: antibody mimic design.
Feng J; Li Y; Zhang W; Shen B
Immunol Lett; 2005 May; 98(2):311-6. PubMed ID: 15860233
[TBL] [Abstract][Full Text] [Related]
11. A trimeric anti-HER2/neu ScFv and tumor necrosis factor-alpha fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia.
Huang TH; Morrison SL
J Pharmacol Exp Ther; 2006 Mar; 316(3):983-91. PubMed ID: 16291729
[TBL] [Abstract][Full Text] [Related]
12. De novo design TNF-alpha antagonistic peptide based on the complex structure of TNF-alpha with its neutralizing monoclonal antibody Z12.
Qin W; Feng J; Li Y; Lin Z; Shen B
J Biotechnol; 2006 Aug; 125(1):57-63. PubMed ID: 16522339
[TBL] [Abstract][Full Text] [Related]
13. [Expression of human tumor necrosis factor receptor-Fc fusion protein and characterization of its biological activity].
Du Z; Wang F; Zhu J; Yu J; Wang Y; Zhu X; Zhang W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Mar; 30(3):225-8. PubMed ID: 24606734
[TBL] [Abstract][Full Text] [Related]
14. A genetically engineered fusion protein M4/TNF with increased bifunctional activity refolded in the presence of protein disulfide isomerase.
Yang J; Raju R; Sharma R; Xiang J
Hum Antibodies Hybridomas; 1995; 6(4):129-36. PubMed ID: 8688495
[TBL] [Abstract][Full Text] [Related]
15. The IL-6/sIL-6R treatment of a malignant melanoma cell line enhances susceptibility to TNF-alpha-induced apoptosis.
Wagley Y; Yoo YC; Seo HG; Rhee MH; Kim TH; Kang KW; Nah SY; Oh JW
Biochem Biophys Res Commun; 2007 Mar; 354(4):985-91. PubMed ID: 17274948
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase-catalyzed covalent multimerization of Camelidae anti-human TNF single domain antibodies improves neutralizing activity.
Plagmann I; Chalaris A; Kruglov AA; Nedospasov S; Rosenstiel P; Rose-John S; Scheller J
J Biotechnol; 2009 Jun; 142(2):170-8. PubMed ID: 19439388
[TBL] [Abstract][Full Text] [Related]
17. Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats.
Guo Z; Wang S; Jiao Q; Xu M; Xu Z
Biomed Pharmacother; 2009 Aug; 63(7):537-42. PubMed ID: 18848768
[TBL] [Abstract][Full Text] [Related]
18. TNF receptor II fusion protein with tandemly repeated Fc domains.
Nagashima H; Kaneko K; Yamanoi A; Motoi S; Konakahara S; Kohroki J; Masuho Y
J Biochem; 2011 Mar; 149(3):337-46. PubMed ID: 21278157
[TBL] [Abstract][Full Text] [Related]
19. [Study on methods and requirements for quality control of recombinant human tumor necrosis factor receptor Fc fusion protein].
Zhang Y; Gao K; Han CM; Rao CM; Wang JZ
Yao Xue Xue Bao; 2003 Mar; 38(3):165-8. PubMed ID: 12830708
[TBL] [Abstract][Full Text] [Related]
20. [Eukaryotic expression of human LIGHT-Fc chimeric molecule and its anti-tumor activity].
Huang G; Bai Y; Jiang M; Li WL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):499-502. PubMed ID: 15169669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
